Amylon Therapeutics is a startup based in the Netherlands, most recent round Seed, 1 tracked investor.
Amylon Therapeutics is a startup based in the Netherlands. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Amylon Therapeutics develops therapies for central nervous system disorders, with a focus on rare genetic diseases, using RNA modulation technology to treat conditions such as Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch type (HCHWA-D).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.